Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

NCT05768854 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: Bisphosphonate
BIOLOGICAL: Setrusumab

Sponsor

Ultragenyx Pharmaceutical Inc